Rayonier Advanced Materials Inc. — Cyborg Score 4/10
Mixed
Specialty Chemicals & Advanced Materials
Strategic Profile
RYAM is actively restructuring its core High Purity Cellulose segment into three focused units—Cellulose Specialties, Biomaterials, and Cellulose Commodities—to drive operational efficiency. The company secured €67 million in green capital in late 2024, including a €30 million preferred equity investment from SWEN Capital Partners for its bioethanol venture in France, which became commercially operational in 2024.
Cyborg Score Rationale
The Altman Z-Score of 1.18 places the company in the distress zone, indicating potential bankruptcy risk within two years. However, management targets over $300 million in run-rate EBITDA by end of 2027 through price increases, efficiency gains, and biomaterials growth. The company faces high leverage but is pursuing strategic transformation.
Top Insights
Stock surged 42% after rejecting a takeover bid of $11-$12 per share from American Industrial Partners in December, signaling management confidence in standalone value creation
Q3 2025 net sales reached $353 million while carrying $794 million in total debt, indicating significant leverage that constrains flexibility
Net margin of -28.29% and gross margin of 8.07% reflect profitability challenges and limited pricing power, though management is pursuing price optimization
Key competitors include Covestro, INVISTA, Solvay, Celanese, and Nippon Paper Industries, in a consolidated specialty materials landscape
Named Competitors
Engineering Plastics and Specialty Films — Diversified materials for automotive and industrial applications
High-Performance Fibers and Polymers — Spandex and engineering polymers for textiles
Specialty Chemicals — Advanced materials across multiple industries
Engineered Materials and Acetates — Specialty cellulose acetates and engineered materials
Recent Developments
(December 2025) Rejected $11-12/share acquisition offer from American Industrial Partners; stock jumped 42%
(November 2025) Announced market cap of approximately $685M with ongoing operational restructuring
(2024) Second-generation bioethanol facility in France became commercially operational
Open the full interactive Rayonier Advanced Materials Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.